Company news
GlaxoSmithKline will put a legal charge of $400 million on its fourth quarter books, related to an ongoing off-label marketing investigation initiated by the US Attorney's office in Colorado.
GlaxoSmithKline will put a legal charge of $400 million on its fourth quarter books, related to an ongoing off-label marketing investigation initiated by the US Attorney's office in Colorado.
Get the most out of
Register for free and enjoy unlimited access to: